Physician profile
Christopher Hope
NPI 1275829319
$31,507.49
in general payments reported to CMS, 2019-2025
18 companies · $8,514 in 2025
The $8,514 reported for 2025 was more than what 91% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2020: $760 · 2021: $918 · 2022: $850 · 2023: $2,204 · 2024: $17K · 2025: $8,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Honoraria: $4,000 · Food and Beverage: $3,961 · Travel and Lodging: $2,807 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,028.75 |
| Honoraria | $4,000.00 |
| Food and Beverage | $3,960.80 |
| Travel and Lodging | $2,806.90 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $27,811.09 | 2019-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,497.39 | 2019-2025 | |
| Harmony Biosciences LLC | $948.48 | 2021-2025 | Wakix |
| Vertex Pharmaceuticals Incorporated | $285.00 | 2023 | |
| Axsome Therapeutics, INC. | $260.15 | 2023-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $145.19 | 2022-2024 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $120.15 | 2019 | |
| Philips North America LLC | $99.02 | 2019 | |
| Fisher & Paykel Healthcare INC | $88.70 | 2022-2025 | Fisher & Paykel Healthcare |
| Eisai INC. | $79.79 | 2022 | |
| Resmed Corp | $49.98 | 2024-2025 | |
| Lilly USA, LLC | $36.59 | 2025 | Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $23.87 | 2025 | |
| Lundbeck LLC | $15.42 | 2019 | |
| Abbott Laboratories | $14.66 | 2024 | Alinity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.05 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.34 | 2019 | |
| 3b Medical, INC. | $8.62 | 2023 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.